Stay updated on Ribociclib Efficacy After CDK4/6 Inhibit Progression Clinical Trial

Sign up to get notified when there's something new on the Ribociclib Efficacy After CDK4/6 Inhibit Progression Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ribociclib Efficacy After CDK4/6 Inhibit Progression Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision: v3.5.0 was added on the page and Revision: v3.4.2 was removed. The trial details such as eligibility criteria, outcomes, and locations remain unchanged.
    Difference
    0.0%
    Check dated 2026-03-18T16:49:06.000Z thumbnail image
  2. Check
    15 days ago
    No Change Detected
  3. Check
    23 days ago
    No Change Detected
  4. Check
    36 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed earlier notices about funding and government operations (v3.4.1). No clinical trial content or eligibility criteria are affected.
    Difference
    0.4%
    Check dated 2026-02-11T09:25:06.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Notice about a lapse in government funding is displayed, and the site revision has been updated to v3.4.1 (replacing v3.4.0). These changes are administrative and do not alter the study details or how users interact with the page.
    Difference
    0.4%
    Check dated 2026-02-04T05:48:06.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Added a glossary toggle and updated metadata captions to include 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'. Removed the previous captions 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.
    Difference
    0.2%
    Check dated 2026-01-28T04:17:43.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Minor software revision updates detected: Revision: v3.3.4 added and Revision: v3.3.3 removed; no trial details, eligibility criteria, or study results are affected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T02:27:23.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    A consolidated Locations section with state site listings (Alabama, Georgia, Illinois, Kansas, New York, Tennessee, Wisconsin) was added and the per-state location subsections were removed. The HHS Vulnerability Disclosure link was removed.
    Difference
    0.8%
    Check dated 2025-12-23T13:30:17.000Z thumbnail image

Stay in the know with updates to Ribociclib Efficacy After CDK4/6 Inhibit Progression Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ribociclib Efficacy After CDK4/6 Inhibit Progression Clinical Trial page.